1
|
Mcguire S: World Cancer Report 2014.
Geneva, Switzerland: World Health Organization, International
Agency for Research on Cancer, WHO Press, 2015. Adv Nutr.
7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Denkert C, Loibl S, Noske A, Roller M,
Müller BM, Komor M, Budczies J, Darb-Esfahani S, Kronenwett R,
Hanusch C, et al: Tumor-associated lymphocytes as an independent
predictor of response to neoadjuvant chemotherapy in breast cancer.
J Clin Oncol. 28:105–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Adams S, Gray RJ, Demaria S, Goldstein L,
Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, et
al: Prognostic value of tumor-infiltrating lymphocytes in
triple-negative breast cancers from two phase III randomized
adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Onc.
32:2959–2966. 2014. View Article : Google Scholar
|
5
|
Dieci MV, Mathieu MC, Guarneri V, Conte P,
Delaloge S, Andre F and Goubar A: Prognostic and predictive value
of tumor-infiltrating lymphocytes in two phase III randomized
adjuvant breast cancer trials. Ann Oncol. 26:1698–1704. 2015.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Mahmoud SM, Paish EC, Powe DG, Macmillan
RD, Grainge MJ, Lee AH, Ellis IO and Green AR: Tumor-infiltrating
CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin
Oncol. 29:1949–1955. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Waldmann T: The contrasting roles of IL-2
and IL-15 in the life and death of lymphocytes: Implications for
the immunotherapy of rheumatological diseases. Arthritis Res.
4:S161–S167. 2002. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Lodolce JP, Burkett PR, Koka RM, Boone DL
and Ma A: Regulation of lymphoid homeostasis by interleukin-15.
Cytokine Growth Factor Rev. 13:429–439. 2002. View Article : Google Scholar : PubMed/NCBI
|
9
|
Marra P, Mathew S, Grigoriadis A, Wu Y,
Kyle-Cezar F, Watkins J, Rashid M, De Rinaldis E, Hessey S,
Gazinska P, et al: IL15RA drives antagonistic mechanisms of cancer
development and immune control in lymphocyte-enriched
triple-negative breast cancers. Cancer Res. 74:4908–4921. 2014.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Terunuma A, Putluri N, Mishra P, Mathé EA,
Dorsey TH, Yi M, Wallace TA, Issaq HJ, Zhou M, Killian JK, et al:
MYC-driven accumulation of 2-hydroxyglutarate is associated with
breast cancer prognosis. J Clin Invest. 124:398–412. 2014.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang P, Wang Y, Hang B, Zou X and Mao JH:
A novel gene expression-based prognostic scoring system to predict
survival in gastric cancer. Oncotarget. 7:55343–55351.
2016.PubMed/NCBI
|
13
|
Thomas PD: The gene ontology and the
meaning of biological function. Methods Mol Biol. 1446:15–24. 2017.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Kanehisa M, Sato Y, Kawashima M, Furumichi
M and Tanabe M: KEGG as a reference resource for gene and protein
annotation. Nucleic Acids Res. 44:D457–D462. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Desantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Nelson BR, Wu F, Liu Y, Anderson DM,
McAnally J, Lin W, Cannon SC, Bassel-Duby R and Olson EN: Skeletal
muscle-specific T-tubule protein STAC3 mediates voltage-induced
Ca2+ release and contractility. Proc Natl Acad Sci USA.
110:11881–11886. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhou F, Liu H, Zhang X, Shen Y, Zheng D,
Zhang A, Lai Y and Li H: Proline-rich protein 11 regulates
epithelial-to-mesenchymal transition to promote breast cancer cell
invasion. Int J Clin Exp Pathol. 7:8692–8699. 2014.PubMed/NCBI
|
19
|
Holland PWH: Evolution of homeobox genes.
Wiley Interdisciplinary Rev Dev Biol. 2:31–45. 2013. View Article : Google Scholar
|
20
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Makiyama K, Hamada J, Takada M, Murakawa
K, Takahashi Y, Tada M, Tamoto E, Shindo G, Matsunaga A, Teramoto
K, et al: Aberrant expression of HOX genes in human invasive breast
carcinoma. Oncol Rep. 13:673–679. 2005.PubMed/NCBI
|
22
|
Soon YH, Bane F, Hughes E and Young LS:
Protein bomarkers Ki67, HOXC10 and HOXC11 for the prediction of
response to endocrine treatment in breast cancer. BMC Proc.
9:A522015. View Article : Google Scholar
|
23
|
Ribbeck K, Groen AC, Santarella R,
Bohnsack MT, Raemaekers T, Köcher T, Gentzel M, Görlich D, Wilm M,
Carmeliet G, et al: NuSAP, a Mitotic RanGTP target that stabilizes
and cross-links microtubules. Mol Biol Cell. 17:2646–2660. 2006.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Iyer J, Moghe S, Furukawa M and Tsai MY:
What's Nu(SAP) in mitosis and cancer? Cell Signal. 23:991–998.
2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Bidkhori G, Narimani Z, Ashtiani SH,
Moeini A, Nowzari-Dalini A and Masoudi-Nejad A: Reconstruction of
an integrated genome-scale co-expression network reveals key
modules involved in lung adenocarcinoma. PLoS One. 8:e675522013.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Espinosa AM, Alfaro A, Roman-Basaure E,
Guardado-Estrada M, Palma Í, Serralde C, Medina I, Juárez E,
Bermúdez M, Márquez E, et al: Mitosis is a source of potential
markers for screening and survival and therapeutic targets in
cervical cancer. PLoS One. 8:e559752013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Gulzar ZG, Mckenney JK and Brooks JD:
Increased expression of NuSAP in recurrent prostate cancer is
mediated by E2F1. Oncogene. 32:70–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Chen L, Yang L, Qiao F, Hu X, Li S, Yao L,
Yang XL and Shao ZM: High levels of nucleolar spindle-associated
protein and reduced levels of BRCA1 expression predict poor
prognosis in triple-negative breast cancer. PLoS One.
10:e01405722015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Giussani M, Merlino G, Cappelletti V,
Tagliabue E and Daidone MG: Tumor-extracellular matrix
interactions: Identification of tools associated with breast cancer
progression. Semin Cancer Biol. 35:3–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Emery LA, Tripathi AC, King C, Kavanah M,
Mendez J, Stone MD, de las Morenas A, Sebastiani P and Rosenberg
CL: Early dysregulation of cell adhesion and extracellular matrix
pathways in breast cancer progression. Am J Pathol. 175:1292–1302.
2009. View Article : Google Scholar : PubMed/NCBI
|
31
|
He L, Wang D, Wei N and Guo Z: Integrated
bioinformatics approach reveals crosstalk between tumor stroma and
peripheral blood mononuclear cells in breast cancer. Asian Pac J
Cancer Prev. 17:1003–1008. 2016. View Article : Google Scholar : PubMed/NCBI
|